Cappelli Eleonora, Felici Giovanni, Weitschek Emanuel
1Department of Engineering, Roma Tre University, Via della Vasca Navale, 70, Rome, 00146 Italy.
2Institute of Systems Analysis and Computer Science, National Research Council, Via dei Taurini, 19, Rome, 00185 Italy.
BioData Min. 2018 Oct 25;11:22. doi: 10.1186/s13040-018-0184-6. eCollection 2018.
In the Next Generation Sequencing (NGS) era a large amount of biological data is being sequenced, analyzed, and stored in many public databases, whose interoperability is often required to allow an enhanced accessibility. The combination of heterogeneous NGS genomic data is an open challenge: the analysis of data from different experiments is a fundamental practice for the study of diseases. In this work, we propose to combine DNA methylation and RNA sequencing NGS experiments at gene level for supervised knowledge extraction in cancer.
We retrieve DNA methylation and RNA sequencing datasets from The Cancer Genome Atlas (TCGA), focusing on the Breast Invasive Carcinoma (BRCA), the Thyroid Carcinoma (THCA), and the Kidney Renal Papillary Cell Carcinoma (KIRP). We combine the RNA sequencing gene expression values with the gene methylation quantity, as a new measure that we define for representing the methylation quantity associated to a gene. Additionally, we propose to analyze the combined data through tree- and rule-based classification algorithms (C4.5, Random Forest, RIPPER, and CAMUR).
We extract more than 15,000 classification models (composed of gene sets), which allow to distinguish the tumoral samples from the normal ones with an average accuracy of 95%. From the integrated experiments we obtain about 5000 classification models that consider both the gene measures related to the RNA sequencing and the DNA methylation experiments.
We compare the sets of genes obtained from the classifications on RNA sequencing and DNA methylation data with the genes obtained from the integration of the two experiments. The comparison results in several genes that are in common among the single experiments and the integrated ones (733 for BRCA, 35 for KIRP, and 861 for THCA) and 509 genes that are in common among the different experiments. Finally, we investigate the possible relationships among the different analyzed tumors by extracting a core set of 13 genes that appear in all tumors. A preliminary functional analysis confirms the relation of part of those genes (5 out of 13 and 279 out of 509) with cancer, suggesting to focus further studies on the new individuated ones.
在下一代测序(NGS)时代,大量生物数据正在被测序、分析并存储在许多公共数据库中,这些数据库的互操作性对于增强数据可访问性往往是必需的。异构NGS基因组数据的组合是一个开放性挑战:分析来自不同实验的数据是疾病研究的一项基本实践。在这项工作中,我们提议在基因水平上结合DNA甲基化和RNA测序NGS实验,以在癌症中进行有监督的知识提取。
我们从癌症基因组图谱(TCGA)中检索DNA甲基化和RNA测序数据集,重点关注乳腺浸润性癌(BRCA)、甲状腺癌(THCA)和肾肾乳头状细胞癌(KIRP)。我们将RNA测序基因表达值与基因甲基化量相结合,作为我们定义的一种新度量,用于表示与一个基因相关的甲基化量。此外,我们提议通过基于树和规则的分类算法(C4.5、随机森林、RIPPER和CAMUR)来分析组合数据。
我们提取了超过15000个分类模型(由基因集组成),这些模型能够以95%的平均准确率区分肿瘤样本和正常样本。从综合实验中,我们获得了约5000个分类模型,这些模型同时考虑了与RNA测序和DNA甲基化实验相关的基因度量。
我们将从RNA测序和DNA甲基化数据分类中获得的基因集与从两个实验整合中获得的基因进行比较。比较结果显示,在单个实验和整合实验中有几个共同的基因(BRCA有733个,KIRP有35个,THCA有861个),以及在不同实验中有509个共同的基因。最后,我们通过提取出现在所有肿瘤中的13个基因的核心集来研究不同分析肿瘤之间可能的关系。初步功能分析证实了其中部分基因(13个中的5个以及509个中的279个)与癌症的关系,这表明应进一步关注新发现的基因。